- GlobeNewswire•6 days ago
NOVATO, Calif., Aug. 23, 2016-- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced upcoming presentations ...
- Barrons.com•7 days ago
Now that Medivation (MDVN) has agreed to be bought by Pfizer (PFE), Citigroup's Yigal Nochomovitz and Yang Huang argue that Ophthotech (OPHT), Puma Biotechnology (PBYI), Lexicon Pharmaceuticals (LXRX), ...
- GlobeNewswire•20 days ago
NOVATO, Calif., Aug. 09, 2016-- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, will present at the following ...
Ultragenyx Pharmaceutical Inc. (RARE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Ask||76.25 x 100|
|Day's Range||62.91 - 67.75|
|52wk Range||46.52 - 133.40|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-12.45|
|Avg Vol (3m)||723,980|
|Dividend & Yield||N/A (N/A)|